Paisley Capital reports 1.8M-share position in Conexeu Sciences Inc. (CNXU)
Rhea-AI Filing Summary
Paisley Capital Holdings Corp reported a significant ownership position in Conexeu Sciences Inc. common stock. As of 06/30/2026, Paisley Capital beneficially owned 1,800,000 shares of Conexeu Sciences Inc. common stock, representing 6.7% of the class.
Paisley Capital, organized in the British Virgin Islands with a principal office in Baar, Switzerland, reported sole voting power and sole dispositive power over all 1,800,000 shares, with no shared voting or dispositive power. The certification section is marked as not applicable, and the filing is signed by Director Jacqueline Elsener on 07/16/2026.
Positive
- None.
Negative
- None.
Key Figures
Beneficial ownership: 1,800,000 shares
Percent of class: 6.7%
Sole voting power: 1,800,000 shares
+3 more
6 metrics
Beneficial ownership
1,800,000 shares
Common Stock of Conexeu Sciences Inc. beneficially owned by Paisley Capital
Percent of class
6.7%
Portion of Conexeu Sciences Inc. common stock class held by Paisley Capital
Sole voting power
1,800,000 shares
Shares over which Paisley Capital has sole power to vote or direct the vote
Sole dispositive power
1,800,000 shares
Shares over which Paisley Capital has sole power to dispose or direct disposition
As-of date
06/30/2026
Date for which the ownership information is stated
Signature date
07/16/2026
Date the Schedule 13G was signed by Director Jacqueline Elsener
Key Terms
beneficially owned, sole voting power, dispositive power, percent of class
4 terms
beneficially owned financial
"Item 4. | Ownership (a) | Amount beneficially owned: 1,800,000"
Beneficially owned describes securities or assets where a person has the economic rights and control—such as the right to receive dividends and to direct voting—even if legal title is held in another name. Think of it like having the keys and using a car that’s registered to someone else: you get the benefits and make decisions. Investors care because beneficial ownership reveals who truly controls value and voting power, affecting corporate decisions and takeover dynamics.
sole voting power financial
"(i) Sole power to vote or to direct the vote: 1,800,000"
Sole voting power is the exclusive right to cast votes attached to a shareholder’s stock without needing approval from anyone else. Like holding the only remote control for a TV, it lets that holder decide corporate matters such as board members, mergers, and policy changes, making it important to investors because it concentrates control and can strongly influence a company’s strategy and the value of its shares.
dispositive power financial
"(iii) Sole power to dispose or to direct the disposition of: 1,800,000"
Dispositive power is the authority to decide the final outcome of an asset, legal claim, contract, or corporate action — in effect the power to dispose of or resolve something. For investors it matters because whoever holds that authority can determine who gets paid, who controls an asset or vote, and how risks and returns are allocated; think of it like holding the key that lets you lock in the winner or loser in a deal.
percent of class financial
"(b) | Percent of class: 6.7%"
Percent of class is the portion of a specific category of securities—such as a company’s common shares, preferred shares, or a bond series—that takes part in or approves a corporate action (vote, consent, tender, etc.). Investors watch this number because it reveals how much support or opposition exists within that particular shareholder group; like counting how many members of a club back a proposal, it can determine whether a plan passes or how influence is distributed.
AI-generated analysis. How Rhea-AI works. Not financial advice.
FAQ
What ownership stake does Paisley Capital hold in Conexeu Sciences Inc. (CNXU)?
Paisley Capital Holdings Corp beneficially owns 1,800,000 shares of Conexeu Sciences Inc. common stock, representing 6.7% of the class as reported in the Schedule 13G.
What dispositive power does Paisley Capital report over CNXU stock?
Paisley Capital has sole dispositive power over 1,800,000 shares of Conexeu Sciences Inc. common stock and no shared dispositive power, meaning it alone can decide if and when to dispose of these shares.
When was Paisley Capital’s CNXU ownership information dated and signed?
The beneficial ownership information is stated as of 06/30/2026, and the Schedule 13G was signed on 07/16/2026 by Director Jacqueline Elsener.
What class of Conexeu Sciences Inc. securities is reported in this Schedule 13G for CNXU?
The filing concerns Common Stock of Conexeu Sciences Inc., identified with CUSIP 20715F100, and details Paisley Capital’s beneficial ownership and control over these shares.